Sanofi CEO: The enterprise AI shift will reshape pharma in 2026 | Fortune

At Davos this year, AI was a key pillar of discussion. Increasingly, people recognize the impact…

At IBM spinoff Kyndryl, the stock dives 50% after an accounting probe and CFO exit: ‘The red flags are already out’ | Fortune

Good morning. Kyndryl Holdings is the latest Fortune 500 company to face an accounting and internal…